Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAbingdon Health Plc

Abingdon Health Plc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
9.0 GBX 0.00(0%)
Last update at 2026-10-27T13:00:00Z
VOLUME
6703
Market Cap
20.94M

Momentum Score

…

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.50
Low
9.50
High
52 Week Price Range
5.10
Low
9.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
9.00
Dividend Yield
-
Revenue TTM
9.57M
Revenue Per Share
0.03
Gross Profit TTM
3.96M
Debt / Equity
0.19
ROE
-50.98%
Net Debt
-0.89M
ROCE
-58.34%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.81M -1.40M -3.56M -21.59M -6.95M
Net income -3.42M -1.27M -3.45M -21.26M -6.97M
Selling general administrative 7.71M 5.07M 5.22M 6.64M 7.55M
Selling and marketing expenses - 0.05M - - -
Gross profit 3.13M 3.68M 2.08M -3.59M 4.14M
Reconciled depreciation 0.61M 0.43M 0.76M 8.83M 0.75M
Ebit -3.73M -1.34M -3.50M -11.86M -5.37M
Ebitda -3.12M -0.92M -2.75M -3.03M -4.62M
Depreciation and amortization 0.61M 0.43M 0.76M 8.83M 0.75M
Operating income -4.03M -1.37M -3.57M -21.53M -6.72M
Other operating expenses 12.45M 7.51M 7.64M 14.70M 16.99M
Interest expense 0.07M 0.06M 0.07M 0.07M 0.23M
Tax provision -0.08M -0.13M -0.10M -0.33M 0.02M
Interest income 0.10M 0.03M 0.09M 0.00M 0.23M
Net interest income 0.01M -0.03M 0.02M -0.07M -0.23M
Income tax expense -0.39M -0.13M -0.10M -0.33M 0.02M
Total revenue 8.43M 6.13M 4.04M 2.83M 11.62M
Total operating expenses 7.15M 5.05M 5.67M 8.27M 9.52M
Cost of revenue 5.30M 2.46M 1.97M 6.43M 7.47M
Total other income expense net 0.22M -0.03M 0.02M -9.73M -1.58M
Net income from continuing ops -3.42M -1.27M -3.45M -21.26M -6.97M
Net income applicable to common shares - - -3.45M -21.26M -6.97M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 9.31M 5.09M 6.06M 12.77M 33.23M
Intangible assets 0.50M 0.15M 0.09M 0.04M 0.47M
Other current assets - 0.58M - 1.35M 0.97M
Total liab 4.01M 2.84M 3.05M 6.34M 11.90M
Total stockholder equity 5.30M 2.25M 3.01M 6.43M 21.33M
Deferred long term liab - - - - 0.39M
Other current liab 1.59M 1.00M 0.23M -0.37M -0.37M
Common stock 0.09M 0.03M 0.03M 0.03M 0.02M
Capital stock 0.05M 0.03M 0.03M 0.03M 0.02M
Retained earnings -32.17M -28.76M -27.46M -24.11M -2.97M
Good will 2.28M 0.38M 0.00M 0.76M 0.76M
Other assets - 0.00M - - 0.39M
Cash 1.92M 1.44M 3.24M 2.40M 4.98M
Total current liabilities 2.92M 1.82M 2.12M 5.32M 10.76M
Current deferred revenue - 0.40M - 0.37M 0.37M
Net debt -0.89M -0.39M -2.22M -1.12M -3.48M
Short term debt 0.26M 0.12M 0.09M 0.27M 0.35M
Short long term debt 0.09M 0.00M 0.00M 0.12M 0.12M
Short long term debt total 1.03M 1.05M 1.02M 1.28M 1.50M
Other stockholder equity 37.04M 30.81M 30.43M 30.51M 24.27M
Property plant equipment - - 1.21M 1.78M 9.04M
Total current assets 5.13M 3.55M 4.76M 10.96M 22.96M
Net tangible assets - - 2.92M 6.40M 20.10M
Net receivables 2.69M 1.08M 1.15M 6.68M 9.12M
Long term debt 0.65M 0.72M 0.71M 0.43M 0.37M
Inventory 0.53M 0.44M 0.33M 0.53M 7.89M
Accounts payable 0.77M 0.60M 2.03M 5.06M 10.40M
Accumulated other comprehensive income 0.34M 0.17M - - -
Non currrent assets other - 0.01M - - -6.70M
Non current assets total 4.18M 1.54M 1.30M 1.81M 10.27M
Capital lease obligations 0.28M 0.33M 0.31M 0.73M 1.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -1.43M -0.02M -0.07M -0.76M -7.28M
Change to liabilities - - -3.18M -5.17M 0.00M
Total cashflows from investing activities -1.43M -0.02M -0.07M -0.76M -7.28M
Net borrowings - 0.00M -0.01M -0.10M 0.03M
Total cash from financing activities 5.08M -0.11M -0.01M 5.92M 20.74M
Net income -3.42M -1.27M -3.45M -21.26M -6.97M
Change in cash 0.48M -1.80M 0.84M -2.58M 0.59M
Begin period cash flow 1.44M 3.24M 2.40M 4.98M 4.39M
End period cash flow 1.92M 1.44M 3.24M 2.40M 4.98M
Total cash from operating activities -3.18M -1.66M 0.91M -7.74M -12.88M
Issuance of capital stock 5.63M 0.00M 0.00M 6.14M 20.70M
Depreciation 0.61M 0.43M 0.76M 8.83M 0.75M
Other cashflows from investing activities 0.10M 0.03M 0.09M 0.00M -0.44M
Change to inventory -0.09M -0.11M 0.20M 2.32M -7.11M
Change to account receivables -0.62M -0.30M 6.65M 2.13M -1.07M
Sale purchase of stock - - - - 20.70M
Other cashflows from financing activities -0.17M -0.11M 0.11M -0.10M 0.06M
Change to netincome - - 0.02M 17.24M 1.53M
Capital expenditures 0.33M 0.04M 0.16M 0.76M 7.25M
Change in working capital -0.54M -0.74M 3.67M -0.71M -8.18M
Stock based compensation 0.21M 0.05M 0.03M 0.23M 1.37M
Other non cash items -0.05M -0.12M -0.27M -0.17M 0.09M
Free cash flow -3.43M -1.70M 0.76M -8.50M -20.13M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABDX
Abingdon Health Plc		 -
-%		 9.00 - 53.19 2.19 3.19 1.81 -0.25
IDHC
Integrated Diagnostics Holdings PLC		 -
-%		 0.48 0.20 12.89 3.33 6.89 3.22 8.79
HVO
hVIVO plc		 -
-%		 5.55 7.05 18.32 0.89 1.01 0.69 2.93
CLBX
CelLBxHealth plc		 -
-%		 0.60 - - 7.05 1.50 6.07 -1.62
GDR
genedrive plc		 0.03
2.44%		 1.05 - 12.38 12.99 10.61 16.54 -6.05

Profile*

Abingdon Health Plc

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

York Biotech Campus, York, United Kingdom, YO41 1LZ

44 19 0440 6050

https://www.abingdonhealth.com

129

Name Title Year Born
Mr. Chris Henry Francis Yates CEO & Director 1974
Ms. Melanie Ross CFO, Company Sec. & Director 1980
Mr. Mark Jones Chief Operating Officer NA
Ms. Brenda Hogan HR Director NA
Mr. Oliver Gardner Chief Commercial Officer NA
Ms. Nina Garrett Head of Assay Devel. NA
Dr. Christopher William Hand Executive Chairman 1961
Mr. Thomas Edward Hayes Secretary, CFO & Director 1976
Mr. Chris Henry Francis Yates President of & Director Abingdon Health USA Inc. 1974
Ms. Nina Garrett Chief Technical Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…